Bortezomib
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67184-0530 -
Application number
ANDA210824 -
SPL ID
7f2d7d7b-99b3-4b68-9bbd-89a8249c66a0 -
SPL set ID
aef02171-bf8a-43ad-b40c-7642623f9802 -
UNII
69G8BD63PP -
RxCUI
402243
What the source publishes
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Active ingredients
- Bortezomib
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Bortezomib",
"splId": "7f2d7d7b-99b3-4b68-9bbd-89a8249c66a0",
"labels": [
{
"setId": "aef02171-bf8a-43ad-b40c-7642623f9802",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aef02171-bf8a-43ad-b40c-7642623f9802",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=aef02171-bf8a-43ad-b40c-7642623f9802"
}
],
"routes": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"labeler": "Qilu Pharmaceutical Co., Ltd.",
"finished": true,
"packaging": [],
"productId": "67184-0530_7f2d7d7b-99b3-4b68-9bbd-89a8249c66a0",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "67184-0530",
"deaSchedule": null,
"genericName": "Bortezomib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BORTEZOMIB",
"strength": "3.5 mg/1"
}
],
"applicationNumber": "ANDA210824",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220502",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175604",
"N0000175075"
],
"upc": [
"0367184053018"
],
"unii": [
"69G8BD63PP"
],
"rxcui": [
"402243"
],
"spl_set_id": [
"aef02171-bf8a-43ad-b40c-7642623f9802"
],
"pharm_class_epc": [
"Proteasome Inhibitor [EPC]"
],
"pharm_class_moa": [
"Proteasome Inhibitors [MoA]"
],
"manufacturer_name": [
"Qilu Pharmaceutical Co., Ltd."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67184-0530_7f2d7d7b-99b3-4b68-9bbd-89a8249c66a0"